Filing Details
- Accession Number:
- 0001127602-20-026862
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-13 16:20:07
- Reporting Period:
- 2020-09-15
- Accepted Time:
- 2020-10-13 16:20:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1667779 | P Michael Spears | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Svp, Ra And Compliance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-15 | 2,500 | $0.00 | 8,947 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2020-10-09 | 13,350 | $29.87 | 22,297 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-10-09 | 8,907 | $29.26 | 31,204 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-10-09 | 22,257 | $246.10 | 8,947 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-10-09 | 13,350 | $0.00 | 13,350 | $29.87 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-10-09 | 8,907 | $0.00 | 8,907 | $29.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-07-27 | No | 4 | M | Direct | |
| 3,735 | 2026-02-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $244.63 to $251.38. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
Billionaire Hedge Funds
